phase readout
saveNCT06413498: A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Kite, A Gilead Company. Phase: PHASE3. Conditions: Multiple Myeloma
view source ↗
comments(0)
5-min edit window · permanent after that